MEG3 and myocardial infarction: Besides, knockdown of MEG3 or EGCG treatment demonstrated a pronounced capacity to impede myocardial infarction size, mitigate myocardial structural alterations, and mitigate cellular apoptosis within the MI models (Fig. 7B–D).